Key Points
In a recent advisory issued by the Indian Pharmacopoeia Commission (IPC), concerns have been raised regarding the safety of the widely used painkiller, Meftal..
The alert highlights the potential risks associated with its active ingredient, mefenamic acid, which has been linked to severe allergic reactions...
DRESS syndrome, known as Drug Rash with Eosinophilia and Systemic Symptoms, has emerged as a significant concern related to the use of Meftal..
However, the recent alert emphasizes the risks associated with mefenamic acid, which extends beyond DRESS syndrome to potential side effects like stomach ulcers, gastrointestinal bleeding, and kidney problems, particularly with prolonged usage...
While Meftal has been effective in pain management, the government's alert emphasizes the importance of prioritizing individual safety and informed decision-making when considering its usage..
You might be interested in
Meftal advisory: Why has government issued a safety alert against painkiller?
08, Dec, 23The Indian Pharmacopoeia Commission issued a drug safety alert about painkiller Meftal as it triggers DRESS syndrome.
Govt body issues safety alert for common period painkiller — what you need to know
08, Dec, 23Mefenamic acid, sold under various brand names such as Meftal, Mefanorm, and Mefkind, can cause DRESS Syndrome, a rare but serious condition that can damage the liver, heart, and lungs.
Painkiller Meftal could cause DRESS syndrome. All you need to know about it
08, Dec, 23The government issued an advisory about the side effects of Meftal - a commonly consumed painkiller - as it could a reaction known as Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome.
Government alerts on Meftal; all about adverse reaction the painkiller can cause
07, Dec, 23Government has issued alert about an adverse reaction of Meftal. The syndrome causes a diverse array of symptoms, from 2 to 8 weeks after initiating the drug. | Health